Furthermore, when monocyte counts were not yet recovered from conditioning chemotherapy, we observed that an increase in T cell activation indicator IFNγ and CRS indicator IL‐6 occurred (Figure 4D,E), which may contribute to CRS of mild intensity and a short duration in these patients (range: 1–9 days) in the trial. The gene discussed is IL6; the disease is congenital rubella syndrome.